Your browser doesn't support javascript.
loading
Late-onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation.
Scarioni, M; Arighi, A; Fenoglio, C; Sorrentino, F; Serpente, M; Rotondo, E; Mercurio, M; Marotta, G; Dijkstra, A A; Pijnenburg, Y A L; Scarpini, E; Galimberti, D.
Affiliation
  • Scarioni M; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy.
  • Arighi A; Dino Ferrari Center, University of Milan, Milan, Italy.
  • Fenoglio C; Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Sorrentino F; Department of Neurology, Alzheimer Center, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Serpente M; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy.
  • Rotondo E; Dino Ferrari Center, University of Milan, Milan, Italy.
  • Mercurio M; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy.
  • Marotta G; Dino Ferrari Center, University of Milan, Milan, Italy.
  • Dijkstra AA; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy.
  • Pijnenburg YAL; Dino Ferrari Center, University of Milan, Milan, Italy.
  • Scarpini E; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy.
  • Galimberti D; Dino Ferrari Center, University of Milan, Milan, Italy.
Eur J Neurol ; 27(12): 2630-2634, 2020 12.
Article in En | MEDLINE | ID: mdl-32894632
ABSTRACT
BACKGROUND AND

PURPOSE:

Mutations in the PSEN1 gene are the most common cause of autosomal-dominant Alzheimer's disease and have been associated with the earliest disease onset. We describe an unusual presentation of the rare R377W PSEN1 mutation with a late age of onset, and we provide for the first time in vivo pathological evidence for this mutation.

METHODS:

A 71-year-old female patient with progressive cognitive decline in the past 3 years and positive family history for dementia underwent neurological evaluation, neuropsychological testing, lumbar puncture, conventional brain imaging, amyloid-positron emission tomography (PET) and extensive genetic screening with a next-generation sequencing technique.

RESULTS:

The diagnostic workup revealed mixed behavioural and amnestic disease features on neuropsychological tests, magnetic resonance imaging, and 18-fluorodeoxyglucose (FDG)-PET. Amyloid-PET detected amyloid deposition in the frontal areas, in the parietal lobes and the precunei. The genetic screening revealed the presence of the rare R377W mutation in the PSEN1 gene.

CONCLUSIONS:

Extensive genetic screening is also advisable for late-onset presentations of Alzheimer's disease, especially in the presence of a positive family history or atypical clinical features.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Alzheimer Disease Limits: Aged / Female / Humans Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Alzheimer Disease Limits: Aged / Female / Humans Language: En Year: 2020 Type: Article